Multiple manufacturers receive FDA approval for generic dapagliflozin to treat type 2 diabetes and lower heart failure risks in high-risk T2D patients.

As semaglutide’s patent expires in India, over 50 pharma brands including Sun Pharma, Dr Reddy’s and Cipla are racing to ...

Most students know that one of the most important steps to take after getting a waitlist notification from a college is to ...

GLP-1 generics enter the world’s diabetes capital and are added to bridal packages to cut ‘food noise’; can they fix India's ...

A spokesperson for the FDA said the agency is coordinating with companies to support efforts to boost the supply of patches ...

When is a generic family crossover not the dullest thing on Earth? When it’s a comfy Citroën glazed in weirdness ...

If account ownership lives in Salesforce, then that rule needs to be explicit. If service history is governed in Dynamics 365 ...

From decoding lab results to prepping for doctor visits, more people are turning to AI for health answers—here’s how to use ...

While the GLP‑1 segment slipped by about Rs.11 crore versus February, tirzepatide alone lost roughly Rs.21 crore in value, ...